Formulation and evaluation of an anti-inflammatory gel containing 2.5% Capparis Brevispina Extract
Crossref DOI link: https://doi.org/10.30574/wjarr.2025.25.3.0959
Published Online: 2025-03-30
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
ASHA NANDABARAM,
MUVVALA SUDHAKAR,
RACHANA NANGUNOORI,
DEEPIKA NADIMINTI,
NAMITHA NALUVALA,
MANOGNA NANDED,
SAIKIRAN PANJALA,
